Disposition of 10000 shares by Robert McCabe of National Health at 57.76 subject to Rule 16b-3
NHI Stock | USD 67.59 0.23 0.34% |
Under 62% of National Health's investor base is looking to short. The analysis of overall sentiment of trading National Health Investors stock suggests that many investors are alarmed at this time. National Health's investing sentiment shows overall attitude of investors towards National Health Investors.
National |
Filed transaction by National Health Investors Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
National Health Fundamental Analysis
We analyze National Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
National Health is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
National Health Investors Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with National Health stock to make a market-neutral strategy. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics with similar companies.
Peers
National Health Related Equities
VTR | Ventas | 2.45 | ||||
GMRE | Global Medical | 1.60 | ||||
SBRA | Sabra Healthcare | 0.85 | ||||
OHI | Omega Healthcare | 0.14 | ||||
CHCT | Community Healthcare | 0.05 | ||||
GMRE-PA | Global Medical | 0.24 | ||||
DOC | Healthpeak Properties | 0.36 | ||||
HR | Healthcare Realty | 0.42 | ||||
UHT | Universal Health | 0.89 |
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |